Literature DB >> 8602000

Age at menopause as a risk factor for cardiovascular mortality.

Y T van der Schouw1, Y van der Graaf, E W Steyerberg, J C Eijkemans, J D Banga.   

Abstract

BACKGROUND: Although an association of occurrence of menopause and subsequent oestrogen deficiency with increased cardiovascular disease has been postulated, studies on this association have not shown convincing results. We investigated whether age at menopause is associated with cardiovascular mortality risk.
METHODS: We studied a cohort of 12115 postmenopausal women living in Utrecht, Netherlands, aged 50-65 years at enrolment in a breast cancer screening project. During follow-up of up to 20 years the women attended screening rounds at which we asked questions on menopausal status, age of menopause, medication use, cardiovascular risk factors, and ovarian function. Deaths were ascertained from the patient's family physicians. Life-table analysis and Cox regression analysis were used to investigate the association between aga at menopause and cardiovascular mortality. All analyses were adjusted for biological age.
FINDINGS: 824 women died of cardiovascular causes. 1459 women had left the study area. The risk of cardiovascular mortality was higher for women with early menopauses than for those with late menopauses. The age-adjusted hazard ratio of age at menopause was 0.982 (95% CI 0-968-0-996, p=0.01)_ie, for each year's delay in the menopause the cardiovascular mortality risk decreased by 2%. The extra risk of early menopause seemed to decrease with biological age (p for interaction 0.07); at biological age 60 the reduction of the annual hazard was 3%, but at age 80 there was no reduction. Adjustment for known cardiovascular risk factors and indicators of ovarian function did not significantly alter the risk estimate.
INTERPRETATION: These results support the hypothesis that longer exposure to endogenous oestrogens protects against cardiovascular diseases. The effect of an early menopause may be more important at younger biological ages.

Entities:  

Mesh:

Year:  1996        PMID: 8602000     DOI: 10.1016/s0140-6736(96)90075-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  100 in total

Review 1.  Evidence-based management of dyslipidemias in women.

Authors:  John C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 2.  Cardiovascular disease and primary ovarian insufficiency.

Authors:  Melissa Wellons
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

3.  A large-scale candidate gene association study of age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Daniel I Chasman; Julie E Buring; Constance Chen; Susan E Hankinson; Guillaume Paré; Stephen Chanock; Paul M Ridker; David J Hunter
Journal:  Hum Genet       Date:  2010-08-24       Impact factor: 4.132

4.  Mosaic aging.

Authors:  Lary C Walker; James G Herndon
Journal:  Med Hypotheses       Date:  2010-01-27       Impact factor: 1.538

5.  Women's Reproductive History and Pre-Clinical Peripheral Arterial Disease in Late Life: The San Diego Population Study.

Authors:  Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel
Journal:  J Womens Health (Larchmt)       Date:  2018-12-01       Impact factor: 2.681

6.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

7.  Longitudinal study of the inception of perimenopause in relation to lifetime history of sexual or physical violence.

Authors:  Jenifer E Allsworth; Sally Zierler; Kate L Lapane; Nancy Krieger; Joseph W Hogan; Bernard L Harlow
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

8.  Cardiovascular Diseases, Aging and the Gender Gap in the Human Longevity.

Authors:  Abraham Aviv
Journal:  J Am Soc Hypertens       Date:  2007-06

9.  Reproductive Health as a Marker of Subsequent Cardiovascular Disease: The Role of Estrogen.

Authors:  JoAnn E Manson; Teresa K Woodruff
Journal:  JAMA Cardiol       Date:  2016-10-01       Impact factor: 14.676

Review 10.  Outcomes of lipid-lowering treatment in postmenopausal women.

Authors:  John C LaRosa
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.